Peter K Vadiveloo

553 total citations
15 papers, 479 citations indexed

About

Peter K Vadiveloo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Peter K Vadiveloo has authored 15 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Peter K Vadiveloo's work include Immune cells in cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Peter K Vadiveloo is often cited by papers focused on Immune cells in cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Peter K Vadiveloo collaborates with scholars based in Australia and Japan. Peter K Vadiveloo's co-authors include John A. Hamilton, Alastair G. Stewart, Darren Fernandes, Trudi Harris, John Wilson, Elizabeth Guida, Heather Stanton, Noel Fidge, G Vairo and Paul J. Hertzog and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

Peter K Vadiveloo

15 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter K Vadiveloo Australia	13	192	172	119	84	68	15	479
Gunnel Östergren‐Lundén Sweden	10	298 1.6×	76 0.4×	62 0.5×	46 0.5×	58 0.9×	12	476
Matthew T. Hardison United States	8	122 0.6×	113 0.7×	102 0.9×	119 1.4×	75 1.1×	9	467
Shen‐Wu Wang China	11	274 1.4×	179 1.0×	133 1.1×	124 1.5×	89 1.3×	20	638
Grant R. Stenton Canada	14	166 0.9×	289 1.7×	171 1.4×	40 0.5×	30 0.4×	23	615
Ling Yin China	12	232 1.2×	107 0.6×	57 0.5×	92 1.1×	34 0.5×	24	511
Suzel Davanture France	10	226 1.2×	318 1.8×	134 1.1×	196 2.3×	32 0.5×	12	643
Diana C. Contreras United States	8	179 0.9×	289 1.7×	49 0.4×	110 1.3×	60 0.9×	11	500
Peter F.J. Verhallen United States	12	211 1.1×	88 0.5×	78 0.7×	27 0.3×	53 0.8×	17	622
Vladimı́r Leksa Slovakia	15	247 1.3×	115 0.7×	45 0.4×	67 0.8×	87 1.3×	24	479
Siyao Liu China	10	143 0.7×	135 0.8×	52 0.4×	149 1.8×	58 0.9×	48	485

Countries citing papers authored by Peter K Vadiveloo

Since Specialization

Citations

This map shows the geographic impact of Peter K Vadiveloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K Vadiveloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K Vadiveloo more than expected).

Fields of papers citing papers by Peter K Vadiveloo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K Vadiveloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K Vadiveloo. The network helps show where Peter K Vadiveloo may publish in the future.

Co-authorship network of co-authors of Peter K Vadiveloo

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K Vadiveloo. A scholar is included among the top collaborators of Peter K Vadiveloo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K Vadiveloo. Peter K Vadiveloo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vadiveloo, Peter K, et al.. (2004). Early Inducible Nitric Oxide Synthase 2 (NOS 2) Activity Enhances Ischaemic Skin Flap Survival. Angiogenesis. 7(1). 33–43. 12 indexed citations

Vadiveloo, Peter K, E. Keramidaris, Wayne A. Morrison, & Alastair G. Stewart. (2001). Lipopolysaccharide-induced cell cycle arrest in macrophages occurs independently of nitric oxide synthase II induction. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1539(1-2). 140–146. 35 indexed citations

Vadiveloo, Peter K, et al.. (2000). Type I Interferons Mediate the Lipopolysaccharide Induction of Macrophage Cyclin D2. Journal of Interferon & Cytokine Research. 20(4). 355–359. 11 indexed citations

Vadiveloo, Peter K, G Vairo, Paul J. Hertzog, Ismail Kola, & John A. Hamilton. (2000). ROLE OF TYPE I INTERFERONS DURING MACROPHAGE ACTIVATION BY LIPOPOLYSACCHARIDE. Cytokine. 12(11). 1639–1646. 55 indexed citations

Stewart, Alastair G., Trudi Harris, Darren Fernandes, et al.. (1999). β2-Adrenergic Receptor Agonists and cAMP Arrest Human Cultured Airway Smooth Muscle Cells in the G₁Phase of the Cell Cycle: Role of Proteasome Degradation of Cyclin D1. Molecular Pharmacology. 56(5). 1079–1086. 54 indexed citations

Stewart, Alastair G., Trudi Harris, Darren Fernandes, et al.. (1999). β2-Adrenergic Receptor Agonists and cAMP Arrest Human Cultured Airway Smooth Muscle Cells in the G1 Phase of the Cell Cycle: Role of Proteasome Degradation of Cyclin D1. Molecular Pharmacology. 56(5). 1079–1086. 2 indexed citations

Fernandes, Darren, Elizabeth Guida, Trudi Harris, et al.. (1999). Glucocorticoids Inhibit Proliferation, Cyclin D1 Expression, and Retinoblastoma Protein Phosphorylation, but Not Activity of the Extracellular-Regulated Kinases in Human Cultured Airway Smooth Muscle. American Journal of Respiratory Cell and Molecular Biology. 21(1). 77–88. 120 indexed citations

Vadiveloo, Peter K. (1999). Macrophages—proliferation, activation, and cell cycle proteins. Journal of Leukocyte Biology. 66(4). 579–582. 35 indexed citations

Vadiveloo, Peter K, et al.. (1998). Proliferation-independent Induction of Macrophage Cyclin D2, and Repression of Cyclin D1, by Lipopolysaccharide. Journal of Biological Chemistry. 273(36). 23104–23109. 19 indexed citations

10.

Hamilton, John A., Robert A. Byrne, Genevieve Whitty, et al.. (1998). Effects of wortmannin and rapamycin on CSF-1-mediated responses in macrophages. The International Journal of Biochemistry & Cell Biology. 30(2). 271–283. 12 indexed citations

11.

Vadiveloo, Peter K, Enrico L Filonzi, Heather Stanton, & John A. Hamilton. (1997). G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. Atherosclerosis. 133(1). 61–69. 45 indexed citations

12.

Vadiveloo, Peter K, et al.. (1994). Interleukin-4 inhibits human smooth muscle cell proliferation.. PubMed. 21(3). 161–81. 34 indexed citations

13.

Vadiveloo, Peter K, et al.. (1993). Interaction of apolipoprotein AII with the putative high-density lipoprotein receptor. Biochemistry. 32(36). 9480–9485. 13 indexed citations

14.

Vadiveloo, Peter K & Noel Fidge. (1992). The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells. Biochemical Journal. 284(1). 145–151. 13 indexed citations

15.

Vadiveloo, Peter K & Noel Fidge. (1990). Studies on the interaction between apolipoprotein A-II-enriched HDL3 and cultured bovine aortic endothelial (BAE) cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1045(2). 135–141. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact